|4Feb 17, 6:40 PM ET

Belloff Neil S. 4

4 · Eloxx Pharmaceuticals, Inc. · Filed Feb 17, 2021

Insider Transaction Report

Form 4
Period: 2021-02-12
Belloff Neil S.
General Counsel and Secretary
Transactions
  • Award

    Stock Options

    2021-02-12+120,000120,000 total
    Exercise: $4.04Exp: 2031-02-12Common Stock (120,000 underlying)
Footnotes (2)
  • [F1]The stock options were issued pursuant to the Issuer's 2018 Equity Incentive Plan.
  • [F2]The options vest and become exercisable over a four-year period, with one-fourth of the shares of common stock underlying the options vesting on February 12, 2022, and the remainder vesting in twelve equal quarterly installments thereafter.

Documents

1 file
  • 4
    form4-02172021_030226.xmlPrimary